Home › Cardiomyopathy › Washington
Cardiomyopathy clinical trials in Washington
4 studies for Cardiomyopathy are looking for participants at sites in Washington.
Cities in Washington
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
- Clinical Trial Site, Seattle
- Clinical Trial Site, Spokane
RecruitingPhase 3
Ages 18 to 85 · All sexes · Updated Sep 16, 2026 · NCT07052903Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System
- Seattle Children's Hospital, Seattle
RecruitingPhase 2
Ages 0 to 16 · All sexes · Updated Aug 10, 2026 · NCT06080074Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- University of Washington Medical Center, Seattle
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Aug 4, 2026 · NCT06563895Modeling Mortality in Duchenne Muscular Dystrophy Cardiomyopathy: Identification of Surrogate Outcome Measures for DMD Drug Trials
- Seattle Children's, Seattle
RecruitingObservational study
All ages · All sexes · Updated Jul 28, 2026 · NCT07674758From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.